Open AccessA phase I/IIa trial using CD19-targeted third-generation CAR T cells for lymphoma and leukemia
Author(s) -
G. Enblad,
H. Karlsson,
G. Gammelgård,
J. Wenthe,
T. Lövgren,
R.M. Amini,
K.I. Wikstrom,
M. Essand,
Barbara Savoldo,
H. Hallböök,
M. Höglund,
Gianpietro Dotti,
M.K. Brenner,
H. Hagberg,
A. Loskog
Publication year - 2018
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/35gn-r519
Subject(s) - lymphoma , cd19 , medicine , cancer research , leukemia , oncology , immunology , antigen